Nutrition 21 announced that the European Food Safety Authority (EFSA) has released its safety assessment supporting the use of chromium picolinate in food supplements in the EU.
In its safety assessment, EFSA concluded that chromium picolinate does not present a safety concern when used as a source of chromium in food supplements. This assessment is an initial step in the procedure for the formal EU approval of chromium picolinate, as an acceptable form of supplemental chromium.
To assist Nutrition 21 in the submission of data for the EFSA to conduct its safety assessment, the company retained Cantox Health Sciences International.
Nigel Baldwin, Ingredient Safety Expert at Cantox Health Sciences International, said: The EFSA’s review and published opinion show the level of detail that we and Nutrition 21 went through to clearly demonstrate chromium picolinate as the form of chromium with the most safety data behind it. We are pleased with the EFSA’s safety assessment of chromium picolinate. The standards set by the EFSA are the gold standards for the rest of the world and we believe this bodes well for Nutrition 21.
William Levi, Vice President of Ingredients, Nutrition 21, said: This is an exciting development for our Ingredients business. Expansion into the EU is an important component of our growth strategy. We already have active business development projects with potential strategic customers, and expect to announce an exclusive arrangement with a leading European ingredients manufacturer to distribute Chromax chromium picolinate throughout Europe upon formal EU approval.